ESSA Pharma Inc. (EPIX) has disclosed a new risk, in the Debt & Financing category.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
ESSA Pharma Inc.’s management holds significant discretion over the allocation of its cash reserves, which poses a potential risk to the company’s operational outcomes. The decisions made regarding these cash resources may not align with shareholder expectations or contribute to enhancing shareholder value. Ineffective utilization of these funds could materially impact ESSA’s business, hinder the progress of product development, and precipitate a decline in the market value of its Common Shares. Furthermore, interim investments of unused cash might not yield substantial income or could potentially depreciate, exacerbating financial challenges.
Overall, Wall Street has a Hold consensus rating on EPIX stock based on 5 Holds.
To learn more about ESSA Pharma Inc.’s risk factors, click here.
